ClinicalTrials.govpublic full text
Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)
colorectal neoplasms, apatinib,bevacizumab,folfiri,colorectal cancer, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 900834
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.